Santos A Susin

13PUBLICATIONS
45CO-AUTHORS
Molecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSocial and affective neuroscience
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 07, 2026
Olaparib sensitizes chronic lymphocytic leukemia to BTK- and BCL2-targeted therapies via PARP1-independent mitochondrial metabolic dysfunction.

Marianne Ayoub, Casilda Hitier, Léa Dehgane

|Dec 09, 2025
REL overexpression and sustained NF-κB signaling associated with 2p gain induce resistance to BTK inhibitors in Chronic Lymphocytic Leukemia.

Léa Dehgane, Eliane Mallet, Constance Brasseur

|Oct 29, 2024
Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes.

Stella Charalampopoulou, Elise Chapiro, Ferran Nadeu

|Dec 06, 2023
ACOX1-mediated peroxisomal fatty acid oxidation contributes to metabolic reprogramming and survival in chronic lymphocytic leukemia.

Mariana Tannoury, Marianne Ayoub, Léa Dehgane

|Sep 28, 2023
The Value of Neutrophil Gelatinase-Associated Lipocalin Receptor as a Novel Partner of CD38 in Chronic Lymphocytic Leukemia: From an Adverse Prognostic Factor to a Potential Pharmacological Target?

Brigitte Bauvois, Elise Chapiro, Claire Quiney

|Sep 26, 2023
del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia.

Ludovic Jondreville, Lea Dehgane, Cecile Doualle

Pageof 3

Frequent Collaborators

5 joint publications

Elise Chapiro

5 joint publications

Delphine Garnier

4 joint publications

Brigitte Bauvois

3 joint publications

Florence Nguyen-Khac